Press Releases
Search
-
24 Jan 2012
bioMérieux - 2011 Business Review
Sales: Up 6.5% at constant exchange rates Including 4.1% organic growth Double-digit growth* in 11 countries Including: India** (up 28%), China (up 20%), Brazil (up 18%) and Turkey (up 18%) Sustained ...
-
14 Dec 2011
Information following the December 7th press release
Marcy l’Etoile (France) - December 14, 2011. At the request of the French “Autorité des Marchés Financiers”, bioMérieux, a world leader in the field of in vitro diagnostics, completes the information ...
-
07 Dec 2011
bioMérieux - Information on 2011 sales objective
Marcy l’Etoile (France) - December 7, 2011. bioMérieux, a world leader in the field of in vitro diagnostics,announces that, based on preliminary data, sales growth at constant exchange rates, for the ...
-
18 Nov 2011
bioMérieux Initiative to Support European Antibiotic Awareness Day
Marcy l’Etoile (France) - November 18, 2011. As the world leader in microbiology and a pioneer in diagnostics for antimicrobial resistance detection and susceptibility testing (AST), bioMérieux active...
-
04 Nov 2011
bioMérieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics
Marcy l'Etoile, France and Lausanne (Switzerland) - November 4, 2010. Co-development of assays and co-distribution of a fully integrated molecular platform due for launch in 2012. bioMérieux gains exc...
-
20 Oct 2011
bioMérieux Business Review for the nine months ended September 30, 2011
Marcy l'Etoile, France - October 20, 2011. Sales: Up 5.2% at constant exchange rates Including 4% organic growth Robust 8% organic growth in clinical microbiology Double-digit organic growth continues...
-
28 Sep 2011
Mise en œuvre du retrait obligatoire visant les actions AES Chemunex
Marcy L'Etoile, France - September 28, 2011. Communiqué de mise à disposition de la note d’information de bioMérieux et de la note en réponse d’AES Chemunex visées par l’AMF, ainsi que des information...
-
06 Sep 2011
bioMérieux - First-Half Results at June 30, 2011
Marcy L'Etoile, France - September 6, 2011. Operating income before non-recurring items Up 5.2% At 17.8% of sales Two strategic acquisitions: AES Laboratoire, making bioMérieux world leader in food te...
-
06 Sep 2011
bioMérieux - First-Half 2011 Business Review
Marcy L'Etoile, France - July 19, 2011. At constant exchange rates and comparable business base* First-half sales up 4.3% Second-quarter sales accelerate: up 5.1% Good performance in North America con...
-
27 Jul 2011
New Study Reports: CancerTYPE ID Expands Tumor Type Coverage and Demonstrates Clinical Utility - CancerTYPE ID is Now a Covered Benefit for Medicare Part B Patients
SAN DIEGO, Calif., - July 27, 2011. bioTheranostics, a bioMérieux company that develops innovative oncology diagnostic tests to support targeted disease management, announced today study results publi...
-
22 Jul 2011
Completion of the AES Chemunex group acquisition and filing of a tender offer for the AES Chemunex shares
Marcy-l’Etoile, France - July 22, 2011. bioMérieux has today acquired the entire capital and voting rights of Skiva (441 886 728 R.C.S. Paris), the parent company of the AES Chemunex group. Through th...
-
19 Jul 2011
bioMérieux Expands its Infectious Disease Offering with Acquisition of ARGENE, Specialized in Molecular Diagnostics for Immunocompromised Patients
Marcy l'Etoile, France - July 19, 2011 . bioMérieux, a world leader in the field of in vitro diagnostics, announced that it has acquired ARGENE, a French company specialized in molecular diagnostics. ...
-
30 Jun 2011
World HAI Forum: Global Call to Action to Fight Antibiotic Resistance
Annecy (France) - June 30, 2011 . Over 70 international experts in medicine, infectious diseases, microbiology and epidemiology, from every continent, gathered at the Fondation Mérieux’s Conference Ce...
-
22 Jun 2011
bioMérieux Launches Groundbreaking Salmonella Detection Technology to Improve Food Safety
Marcy l’Etoile - June 22, 2011. bioMérieux, a world leader in the field of in vitro diagnostics, today announced the launch of a new, innovative food safety testing method, VIDAS® UP Salmonella (SPT).
-
24 May 2011
bioMérieux Receives FDA Clearance for NucliSENS EasyQ® MRSA, Automated, Rapid Molecular Screening Test
Marcy l’Etoile, France - May 24, 2011 . bioMérieux, a world leader in the field of in vitro diagnostics, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA...